Cure My Disease

Don't miss your cure!

 Log in / Sign up

Brain zaps boost therapy for PTSD in troops with head injuries

NCT ID NCT07715799

Not yet recruiting Symptom relief Sponsor: The University of Texas Health Science Center at San Antonio Source: ClinicalTrials.gov ↗

First seen Jul 20, 2026 · Last updated Jul 21, 2026 · Updated 1 time

Summary

This study tests whether a gentle brain stimulation technique called tDCS can make a standard talk therapy for PTSD work better. Military personnel and veterans with both PTSD and a history of mild to moderate traumatic brain injury will receive five weekly sessions of written exposure therapy. Half will also get real tDCS to the front of the brain, while the other half gets a sham version. Researchers will track PTSD and brain injury symptoms for six months after treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcranial direct current stimulation (tDCS) combined with written exposure therapy (WET)
What this could lead to
If it works, this could offer a more effective, non-drug treatment for PTSD in people with traumatic brain injury.
What could go wrong
This is an early-stage trial with a moderate number of participants. The sham group may also improve, and results may not apply to all PTSD patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POST-TRAUMATIC STRESS DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

post-traumatic stress disorder traumatic brain injury

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

POST-TRAUMATIC STRESS DISORDER

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The University of Texas Health Science Center at San Antonio

    San Antonio, Texas, 78229, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.